Order results by:
| Issue | Title | |
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... in ADDs (р<0.001) and fatigue (mean MFI-20 scores decreased from 42.28±10.73 to 35.60±8.10; р<0.001 ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... Search for agents for the add-on therapy of multiple sclerosis (MS) that can enhance the effect ..." | ||
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... based on their efficacy and safety profiles. Curcumin is being considered as an add-on therapy due ..." | ||
| Vol 15, No 4 (2023) | Comorbid disorders and therapy of persistent postural perceptual dizziness | Abstract similar documents |
| E. N. Zastenskaya, L. M. Antonenko | ||
| "... in the group with PPPD and ADD from 30.00±6.99 to 16.12±4.16 points (p<0.001), in the group with PPPD ..." | ||
| Vol 15, No 5 (2023) | Possibilities of combined use of peptides in the treatment of post-stroke asthenia | Abstract similar documents |
| A. Yu. Emelin, V. Yu. Lobzin | ||
| "... , the presence of which is associated with unfavourable course of the disease. Post-stroke fatigue is, on the one ..." | ||
| Vol 8, No 1 (2016) | Multiple sclerosis-related fatigue and possibilities of its correction | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... Multiple sclerosis (MS)-related fatigue is encountered in 75–92% of patients and it is one ..." | ||
| Vol 13, No 1 (2021) | Fatigue in patients with chronic inflammatory demyelinating polyneuropathy | Abstract PDF (Eng) similar documents |
| R. A. Gapeshin, E. R. Barantsevich, D. I. Rudenko, T. R. Stuchevskaya, E. A. Gavrilova, M. S. Pushkaryov, A. A. Yakovlev, A. V. Gavrichenko, A. G. Smochilin | ||
| "... motor neuropathy, with a progressive or relapse-remitting course. Fatigue is a condition characterized ..." | ||
| Vol 3, No 4 (2011) | Neurasthenia: history and the present | Abstract similar documents |
| D. Yu. Veltishchev | ||
| Vol 7, No 2 (2015) | The symptoms of pathological fatigue, apathy, and depression in patients after stroke | Abstract similar documents |
| M. A. Kutlubaev, L. R. Akhmadeeva | ||
| "... fatigue, apathy, and depression in patients in the termination phase of an acute stroke period. Patients ..." | ||
| Vol 15, No 2 (2023) | Quality of life of patients with rheumatoid arthritis and comorbid fibromyalgia | Abstract similar documents |
| N. A. Melikova, E. S. Filatova, E. G. Filatova, A. M. Lila | ||
| "... and severity of fatigue (FSS), anxiety and depression (HADS), sleep disorders (PSQI), cognitive impairment ..." | ||
| Vol 16, No 4 (2024) | Treatment of post-traumatic cognitive disorders and asthenia: results of an observational study | Abstract similar documents |
| P. R. Kamchatnov, O. Yu. Tsarapkina, N. G. Malyukova, A. V. Miretskaya, E. F. Danshina, L. A. Skipetrova, R. A. Cheremin | ||
| "... .9 years) with complaints of CI and fatigue after TBI received within the last 2 years, who were prescribed ..." | ||
| Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
| Vol 16, No 1 (2024) | Evaluation of the therapeutic efficacy of the drug Cytochrome C in the treatment of asthenia in outpatients (CITRIN study) | Abstract similar documents |
| V. Yu. Lobzin, A. Yu. Emelin, K. A. Kolmakova | ||
| "... % – from 9.1±5.6 to 4.6±4.3 points (p<0.001), reduction in severity of fatigue by 29% (p<0 ..." | ||
| Vol 13, No 1 (2021) | The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ | Abstract similar documents |
| V. V. Kovalchuk | ||
| "... -up, the frequency of complaints of cognitive impairment, sleep disorder, dizziness, fatigue ..." | ||
| Vol 14, No 2 (2022) | New potential biomarkers of Alzheimer's disease: markers of endothelial dysfunction and neuroinflammation. | Abstract similar documents |
| A. K. Minochkin, V. Yu. Lobzin, N. N. Suchentseva, O. S. Popov, S. V. Apalko, S. G. Sherbak | ||
| "... Assessment Battery (FAB), Montreal Cognitive Assessment (MoCA), and etc. Results and discussion ..." | ||
| Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
| N. V. Zarubina, N. N. Spirin | ||
| "... and exacerbations (p<0.001). MS patients with depression significantly more often (p<0.01) complained of increased ..." | ||
| Vol 13, No 2 (2021) | Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19) | Abstract similar documents |
| V. A. Kutashov | ||
| "... assessed with Montreal Cognitive Assessment (Montreal Cognitive Assessment test, МоСA test), fatigue ..." | ||
| Vol 17, No 3 (2025) | Switching from ocrelizumab to ofatumumab: key potential reasons based on real-world clinical practice | Abstract similar documents |
| A. N. Boyko, T. O. Simaniv, T. A. Prokopyeva, S. V. Petrov, M. V. Melnikov | ||
| "... relevant factor is the phenomenon of "treatment fatigue" associated with regular intravenous infusions ..." | ||
| Vol 4, No 1 (2012) | Use of Addenbrooke’s cognitive examination-revised to evaluate the patients’ state in general medical practice | Abstract similar documents |
| Nikolai Nikolayevich Ivanets, D M Tsarenko, M A Bobrova, A A Kursakov, E G Starostina, A E Bobrov | ||
| "... оценки психического статуса (КШОПС); батарея лобной дисфункции (FAB); ACE-R; методика «Заучивание десяти ..." | ||
| Vol 12, No 1 (2020) | The efficacy and safety of ethyl methyl hydroxypyridine succinate used as part of sequential therapy in patients with chronic cerebral ischemia | Abstract similar documents |
| V. V. Burdakov, D. V. Krasnykh | ||
| "... (Multidimensional Fatigue Inventory, MFI-20); and the Clinical Global Impression (CGI) scale over time. Results ..." | ||
| Vol 12, No 4 (2020) | Possibilities of drug therapy for vascular cognitive impairment: a critical view and possible compromises | Abstract similar documents |
| A. Yu. Emelin, V. Yu. Lobzin | ||
| "... in combination therapy as add-on treatment, by taking into account individual indications. It is concluded ..." | ||
| Vol 16, No 5 (2024) | Clinical features of vascular cognitive impairment | Abstract similar documents |
| O. O. Martynova, N. V. Vakhnina, V. V. Zakharov | ||
| "... function (MoCA test, MMSE); general EF (FAB, EXIT-25); episodic memory (12-word memory test and Benton ..." | ||
| Vol 9, No 2 (2017) | Mental status in pregnant women with brain injury sequels | Abstract similar documents |
| A. A. Volynkin, P. N. Vlasov, V. A. Petrukhin, K. N. Akhvlediani | ||
| "... examination using the Miltidimensional Fatigue Inventory-20 (MFI-20), the Hospital Anxiety and Depression ..." | ||
| Vol 13, No 6 (2021) | Role of chondroitin sulfate in the regulation of neuroimmunoendocrine network interactions in patients with neurological symptoms in the post-covid period | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, M. Yu. Maksimova, M. N. Sharov, Yu. S. Prokofyeva | ||
| "... indications in patients with and myalgic encephalomyelitis/chronic fatigue syndrome after SARS-CoV-2 infection ..." | ||
| Vol 10, No 4 (2018) | Approaches to therapy for depressions in neurology: prospects for the use of agomelatine | Abstract similar documents |
| D. V. Romanov, B. A. Volel, D. S. Petelin | ||
| "... ’s disease, chronic fatigue syndrome, and pain syndromes. ..." | ||
| Vol 10, No 4 (2018) | Cognitive, emotional, and behavioral disorders in hypertensive patients | Abstract similar documents |
| S. K. Abduraimova, V. V. Zakharov, A. R. Kabaeva | ||
| "... features of depression, such as the prevalence of anhedonia and fatigue and the significant severity ..." | ||
| Vol 17, No 2 (2025) | Multitarget transcranial magnetic theta-burst stimulation in the correction of cognitive impairment in patients with progressive multiple sclerosis | Abstract PDF (Eng) similar documents |
| A. Kh. Zabirova, I. S. Bakulin, A. G. Poydasheva, D. Yu. Lagoda, M. N. Zakharova, E. V. Gnedovskaya, N. A. Suponeva, M. A. Piradov | ||
| "... and questionnaires on subjective CI and fatigue. Results. No serious adverse events (AEs) or discontinuation of TMS ..." | ||
| Vol 11, No 2 (2019) | Susceptibility-weighted MR imaging (SWI) of basal ganglia iron deposition in the early and advanced stages of Parkinson's disease | Abstract similar documents |
| A. G. Trufanov, A. A. Yurin, A. B. Buriak, S. A. Sandalov, M. M. Odinak, I. V. Litvinenko | ||
| "... State Examination (MMSE), Frontal Assessment Batter (FAB), Freezing of Gait (FOG), Gait and Balance ..." | ||
| Vol 16, No 5 (2024) | Asthenia and vascular cognitive impairment in young patients after stroke | Abstract similar documents |
| L. A. Shchepankevich, K. V. Rerikh, M. S. Ponomareva, A. V. Zatynko, E. V. Taneeva | ||
| "... was assessed by Montreal Cognitive Assessment (MoCA) and asthenia by manifestations of general fatigue ..." | ||
| Vol 15, No 4 (2023) | Psychosocial factors and sleep disorders in the population aged 25–64 years in Russia/Siberia (International WHO MONICA-Psychosocial Programme) | Abstract similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. V. Gafarova | ||
| "... of: anxiety (HLA) in 61.8% of men (χ2=56.169; df=4; p<0.001) and 68.1% of women (χ2=36.535; df=4; p<0.001 ..." | ||
| Vol 13, No 5 (2021) | Pathobiochemical pathways of redox imbalance in the neurological long-term effects of COVID-19 and the role of chondroitin sulfate in the redox status restoration | Abstract similar documents |
| I. V. Sarvilina, O. A. Gromova, A. V. Naumov | ||
| "... . The mechanism of action and neuroprotective effects of chondroitin sulfate and its derivatives in fatigue ..." | ||
| Vol 7, No 2 (2015) | Gender features of depressive disorders in women | Abstract similar documents |
| N. A. Tyuvina, V. V. Balabanova, E. O. Voronina | ||
| "... , fatigue, increased appetite, weight gain, hypersomnia, and signs of somatization), as well as rarer ..." | ||
| Vol 3, No 3 (2011) | Neuropsychiatrie disorders in Parkinson's disease and their correction with the MAO-B inhibitor rasagiline (Azilect®) | Abstract similar documents |
| M. R. Nodel | ||
| "... depression inventory, the PD fatigue scale, the PD sleep scale, the Epworth sleeping scale, and the PD ..." | ||
| Vol 3, No 1 (2011) | Sleep disorders in Parkinson's disease | Abstract similar documents |
| M. R. Nodel | ||
| "... ), the PD sleep scale (PDSS), the Beck depression inventory and PD fatigue scale (PFS-16), the scales ..." | ||
| Vol 15 (2023): (Suppl. 1) | The place of virtual reality in the rehabilitation of patients with multiple sclerosis | Abstract similar documents |
| Iu. E. Korzhova, A. A. Fuks, A. S. Klochkov, A. E. Khizhnikova, N. A. Suponeva, M. N. Zakharova | ||
| "... were selected. The efficacy of VR in reducing symptoms of MS such as fatigue, balance disturbances ..." | ||
| Vol 17, No 1 (2025) | The use of antipsychotics in the real-world clinical practice in Russia (based on the results of the EPIDEMICUS program) | Abstract similar documents |
| V. E. Medvedev | ||
| "... . For other mental disorders, doctors more frequently added quetiapine to the therapy (23.2%; p<0.001 ..." | ||
| Vol 12, No 4 (2020) | Diagnosis and treatment of migraine: Russian experts' recommendations | Abstract similar documents |
| E. G. Filatova, V. V. Osipova, G. R. Tabeeva, V. A. Parfenov, E. V. Ekusheva, Yu. E. Azimova, N. V. Latysheva, M. V. Naprienko, K. V. Skorobogatykh, A. V. Sergeev, V. A. Golovacheva, E. R. Lebedeva, A. R. Artyomenko, O. V. Kurushina, M. I. Koreshkina, A. V. Amelin, L. R. Akhmadeeva, A. R. Rachin, E. D. Isagulyan, Al. B. Danilov, A. B. Gekht | ||
| "... criteria as laid down in the International Classification of Headache Disorders, 3 rd edition. Add ..." | ||
| Vol 13, No 3 (2021) | Validation of a Russian version of the Berg Balance Scale | Abstract similar documents |
| N. A. Suponeva, D. G. Yusupova, A. A. Zimin, A. B. Zaitsev, K. A. Yatsko, D. A. Melchenko, A. A. Rimkevichus, E. S. Zhirova, A. S. Taratukhina, A. S. Rizvanova, G. A. Gatina, M. E. Kalinkina, M. A. Piradov, K. Berg | ||
| "... points), reliability (Pearson's correlation coefficient r=0.98, р<0.0001; Cronbach's alpha α=0.94 р<0.001 ..." | ||
| Vol 14, No 4 (2022) | Smoking and sleep disorders (population-based study under the WHO “MONICA-psychosocial” program) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelgorn, A. V. Gafarova | ||
| "... – 12.2%) and 78.6% of women (satisfactory sleep – 58.9%, poor sleep – 19.7%; χ2 =38.553; df=2; p<0.001 ..." | ||
| Vol 15, No 6 (2023) | NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational study | Abstract similar documents |
| A. B. Danilov, A. A. Pilipovich, M. V. Pyastolova | ||
| "... on the VAS before treatment versus 10 [0; 20] after treatment; p<0.0001) and normalisation of sleep in most ..." | ||
| Vol 13, No 5 (2021) | Awareness of cardiovascular diseases risk factors, attitude towards their health and sleep disorders among the 25–64 years old population in Russia/Siberia (WHO International «MONICA-psychosocial» program) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelhorn, A. V. Gafarova | ||
| "... that they were «not entirely healthy» (men – 65.5%, χ2 =57.825, df=8, p<0.001 and women – 69.6%, χ2 =96.883, df=4 ..." | ||
| Vol 12, No 6 (2020) | Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke | Abstract PDF (Eng) similar documents |
| S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, К. V. Sobyanin | ||
| "... .7 [30.5; 39.9] ml/m2 vs 28.5 [25.6; 34.6] ml/m2 vs 27.1 [24.5; 31.2] ml/m2 ; p< 0.001) and NT-proBNP ..." | ||
| Vol 15, No 6 (2023) | Chronic dizziness: modern treatment methods taking into account comorbidity | Abstract similar documents |
| E. N. Zastenskaia, L. M. Antonenko | ||
| "... decreased from 45.59±15.47 to 29.9±12.56 points (p<0.001), the severity of anxiety according to BAI from 27 ..." | ||
| Vol 10, No 3 (2018) | Clinical features of depression in women compared with men | Abstract PDF (Eng) similar documents |
| N. A. Tyuvina, E. O. Voronina, V. V. Balabanova, Yu. G. Tyulpin | ||
| "... of contacts with others; weakness; fatigue; decreased or increased appetite; sleep onset insomnia; lack ..." | ||
| Vol 12, No 3 (2020) | Cervical dystonia: non-motor aspects | Abstract similar documents |
| O. A. Druzhinina, N. G. Zhukova, L. P. Shperling, D. A. Novotnyi | ||
| "... Fatigue Inventory (MFI-20) and the scale of asthenic state (SAS), night sleep quality by the Pittsburg ..." | ||
| Vol 8, No 3 (2016) | Epidemiological study of vital exhaustion and sleep disorders in dwellers of Siberia | Abstract similar documents |
| I. V. Gagulin, V. V. Gafarov, E. A. Gromov, A. V. Gafarova, D. O. Panov | ||
| "... the incidence of fatigue, interrupted sleep, lethargy, the degree of irritability, and a feeling of exhaustion ..." | ||
| Vol 9, No 2 (2017) | Chemoreactomic analysis of citrulline malate molecules | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. E. Fedotova, A. N. Gromov, K. V. Rudakov | ||
| "... are functional asthenia, asthenic syndrome, overfatigue, increased fatigue, and rehabilitation during recovery ..." | ||
| Vol 6, No 2 (2014) | Experience with non-drug therapies (psychotherapy, phytotherapy, reflexotherapy) for neurasthenia | Abstract similar documents |
| S.A Bozhko, N.A. Tyuvina | ||
| "... the Clinical Global Impression Scale (CGI), the Spielberger-Hanin test, and the multidimensional fatigue ..." | ||
| Vol 6, No 2 (2014) | Postherpetic neuralgia: Therapeutic and prophylactic aspects and pregabalin therapy | Abstract similar documents |
| E.G. Mendelevich, S.V. Mendelevich | ||
| "... syndrome in PHN can reach a high intensity level, accompanied by the development of chronic fatigue ..." | ||
| Vol 3, No 4 (2011) | Parkinson's disease fatigability and its correction with the dopamine receptor agonist pramipexole | Abstract similar documents |
| M. R. Nodel | ||
| "... 2.68±0.62) without dementia were examined using the PD fatigue scale (PFS-16), unified PD rating ..." | ||
| Vol 5, No 2 (2013) | Neurasthenia: State-of-the-art and therapeutic approaches | Abstract similar documents |
| Leonid Semenovich Chutko, S Yu Surushkina, I S Nikishena, E A Yakovenko, T I Anisimova | ||
| "... examined using a subjective asthenia rating scale (Multidimensional Fatigue Inventory (MFI-20)), a 10-point ..." | ||
| Vol 15, No 4 (2023) | Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin | Abstract similar documents |
| L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... of the patients were poor concentration, fatigue, forgetfulness, mood lability, sleep disturbances, more often ..." | ||
| Vol 15, No 3 (2023) | Mental disorders during the pandemic of a new coronavirus infection: clinical features | Abstract similar documents |
| V. A. Vysokova, N. A. Tyuvina, T. N. Maksimova, S. V. Prokhorova | ||
| "... , severe apathy, hypersomnia and lack of sleep, fatigue, increased appetite, and complaints of impaired ..." | ||
| Vol 10, No 4 (2018) | Research Institute of Internal and Preventive Medicine, Branch, Federal Research Center, Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences | Abstract similar documents |
| A. V. Titarenko, S. V. Shishkin, L. V. Shcherbakova, E. G. Verevkin, M. Holmes, M. Bobak, S. K. Malyutina | ||
| "... groups, which was steeper in women than in men (p<0.001). Persons aged 70 years and older showed negative ..." | ||
| Vol 8, No 1 (2016) | Changes in spastic muscles of patients with infantile cerebral palsy according to ultrasound findings | Abstract similar documents |
| S. V. Vlasenko, G. M. Kushnir, T. F. Golubeva, E. A. Osmanov, E. V. Strashko | ||
| "... ), and age at contracture formation (R=0.60; p=0.001). Analysis of USG and electromyographic findings ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... scores of the MoCA (p=0.004), the 12- word recall test (p=0.0003), and the tests of literal (p=0.001 ..." | ||
| Vol 11, No 1 (2019) | Role of the intact hemisphere in determining the rehabilitation potential in the acute period of ischemic stroke: a diffusion and perfusion model | Abstract similar documents |
| N. A. Kaileva, A. A. Kulesh, N. Kh. Gorst, A. Yu. Bykova, V. E. Drobakha, K. V. Sobyanin, I. N. Shardakov, V. V. Shestakov | ||
| "... NIHSS value (r = 0.55; p < 0.001), the size of a focus (r = 0.42; p < 0.001), FA in the contralateral ..." | ||
| Vol 11, No 1 (2019) | Social support and stroke risk: an epidemiological study of a population aged 25–64 years in Russia/Siberia (the WHO MONICA-psychosocial program) | Abstract PDF (Eng) similar documents |
| A. V. Gafarova, E. A. Gromova, D. О. Panov, I. V. Gagulin, E. A. Krymov, V. V. Gafarov | ||
| "... .8% of women (χ2=22.603; df=2; p=0.0001) and a low SNI in 43.5% of men and in 33.9% of women (χ2=21.546; df=2 ..." | ||
| Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
| E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
| "... .05-0.001). There were statistically significant differences in the measures of short-term (5.9±0 ..." | ||
| Vol 7, No 1 (2015) | Vascular cognitive impairments in chronic kidney disease | Abstract similar documents |
| I. V. Rogova, V. V. Fomin, I. V. Damulin, E. G. Minakova, O. Yu. Selivanova, Yu. A. Petleva | ||
| "... –IV than in those with Stages I–II, as shown by the scores of the mini-mental state examination (p<0.001 ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... was decreased in patients in group 2 (p<0.001), asymmetry of the indicator was noted, in several patients ..." | ||
| Vol 16, No 3 (2024) | Fremanezumab in real-life clinical practice: specialized headache center experience | Abstract similar documents |
| Yu. E. Azimova, K. V. Skorobogatikh, V. V. Osipova, D. Z. Korobkova, N. V. Vashchenko, E. Z. Mamkhegov, A. S. Galanina, E. A. Guziy | ||
| "... .2 (before treatment) to 8.5±7.9 after 12 weeks (p<0.0001), in the EM group from 10.9±4.1 to 3.6±3.7 (p<0.0001 ..." | ||
| Vol 17, No 3 (2025) | Efficacy and safety of intravenous thrombolytic therapy in patients with ischemic stroke and mild neurological deficit | Abstract similar documents |
| M. R. Suleymanova, T. V. Danilova, D. R. Khasanova | ||
| "... ,84)=1882; p<0.001) and a better functional outcome according to the modified Rankin Scale (U(82,84)=1854; p ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis | Abstract similar documents |
| Ya. V. Vlasov, N. G. Polyarnaya, A. N. Boyko | ||
| "... , and a higher level of fatigue than patients with relapsing-remitting MS (RRMS). Another unfavorable course ..." | ||
| Vol 12, No 5 (2020) | On the heterogeneity of depression in Parkinson’s disease | Abstract similar documents |
| M. R. Nodel, N. N. Yakhno | ||
| "... (UPDRS), the Beck Depression Inventory (BDI), and the Spielberger Inventory, the 16-Item PD Fatigue Scale ..." | ||
| Vol 12, No 2 (2020) | Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome | Abstract similar documents |
| V. E. Medvedev, R. A. Kardashyan, V. I. Frolova, A. M. Burno, S. V. Nekrasova, V. I. Salyntsev | ||
| "... assessment (Multidimensional Fatigue Inventory (MFI-20)). The UKU side effect rating scale was used to verify ..." | ||
| Vol 15, No 4 (2023) | Experience with agomelatine therapy for non-psychotic depression with a single and recurrent course | Abstract similar documents |
| L. A. Ivanova, A. V. Kovaleva, N. O. Sitnikova | ||
| "... agomelatine at a dose of 50 mg discontinued the study: in one case persisted social phobia, increased fatigue ..." | ||
| Vol 13, No 3 (2021) | Sleep disorder trends in 1988–2018 among the 25–64 years old population in Russia/Siberia (WHO MONICA Psychosocial study) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelgorn, A. V. Gafarova | ||
| "... (χ2 =122.061; υ=16; p<0.001 – men; χ2 =230.626; υ=16; p<0.001 – women). In 1988–2018 there was a 2 ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... from 19.8 to 23.3 points (p≥0.001) was observed in the omberacetam group. In other groups, an increase ..." | ||
| Vol 14, No 3 (2022) | The impact of non-motor disorders on the quality of life of patients with cervical muscular dystonia | Abstract similar documents |
| M. R. Nodel, N. I. Salouhina, V. A. Tolmacheva | ||
| "... <0.001 ), moderate strength correlation – with indicators of anxiety (r=0.65; p<0 ..." | ||
| 1 - 70 of 144 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
